Skip to main content

Bruce Thornton

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Bruce Thornton

Earlier roles on record: COO at Sonoma Pharmaceuticals, Inc. (SNOA) until October 18, 2025. Sonoma Pharmaceuticals, Inc. reported in an 8-K filed October 23, 2025 that Bruce Thornton was terminated as Executive Vice President and Chief Operating Officer, effective October 18, 2025. Sonoma Pharmaceuticals, Inc. reported in an 8-K filed October 9, 2025 that Bruce Thornton retired as Executive Vice President and Chief Operating Officer, effective December 2, 2025. The proxy statement of Sonoma Pharmaceuticals, Inc. reports total compensation of $399,635 for Bruce Thornton in fiscal 2026, including a base salary of $170,502. Disclosed compensation is on record for 8 fiscal years.

“On October 18, 2025, Bruce Thornton was terminated as an employee and Executive Vice President and Chief Operating Officer of the Company, and from any other position at the Company or any of its subsidiaries to which he has been appointed.”
Sonoma Pharmaceuticals, Inc. Form 8-K, filed October 23, 2025 · Read the filing
“On October 3, 2025, our Executive Vice President and Chief Operating Officer, Bruce Thornton, notified us of his intent to retire from his position with the Company effective December 2, 2025, and we have determined to eliminate the position of Chief Operating Officer upon Mr. Thornton's departure.”
Sonoma Pharmaceuticals, Inc. Form 8-K, filed October 9, 2025 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2026 Sonoma Pharmaceuticals, Inc. (SNOA) $170,502 $399,635
2025 Sonoma Pharmaceuticals, Inc. (SNOA) $260,800 $532,369
2024 Sonoma Pharmaceuticals, Inc. (SNOA) $255,400 $658,568
2023 Sonoma Pharmaceuticals, Inc. (SNOA) $245,192 $484,653
2022 Sonoma Pharmaceuticals, Inc. (SNOA) $250,000 $554,000
2021 Sonoma Pharmaceuticals, Inc. (SNOA) $253,000 $517,000
2020 Sonoma Pharmaceuticals, Inc. (SNOA) $250,000 $366,000
2019 Sonoma Pharmaceuticals, Inc. (SNOA) $250,000 $310,508

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.